Association between gene expression profile, proliferation and metastasis in uveal melanoma

Current Eye Research

Volumn 35, Issue 9, 2010, Pages 857-863

  Onken, Michael D ^a   Worley, Lori A ^a   Harbour, J William ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Choroid; Ciliary body; Eye; Gene expression profile; Metastasis; Proliferation; Survival; Uveal melanoma

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 3; CHROMOSOME 8P; CHROMOSOME LOSS; CILIARY BODY; CILIARY BODY TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIOID CELL; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MALE; METASTASIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR CLASSIFICATION; TUMOR VOLUME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MIDDLE AGED; RNA, MESSENGER; UVEAL NEOPLASMS;

EID: 77956149503     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.493265     Document Type: Article

References (18)

1. Onken MD, Worley LA, Ehlers JP, et al. Gene expression profling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64:7205-7209.
2. Worley LA, Onken MD, Person E, et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res. 2007;13:1466-1471.
3. Petrausch U, Martus P, Tonnies H, et al. Signifcance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye. 2007;22:997-1007.
4. van Gils W, Lodder EM, Mensink HW, et al. Gene expression profling in uveal melanoma: Two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci. 2008;49:4254-4262.
5. Chang SH, Worley LA, Onken MD, et al. Prognostic bio-markers in uveal melanoma: Evidence for a stem celllike phenotype associated with metastasis. Melanoma Res. 2008;18:191-200.
6. Ehlers JP, Worley L, Onken MD, et al. Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res. 2008;14:115-122.
7. Onken MD, Worley L, Harbour JW. A metastasis modi-fer locus on human chromosome 8p in uveal melanoma identifed by integrative genomic analysis. Clin Cancer Res. 2008;14:3737-3745.
8. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13-20.
9. Mooy CM, de Jong PT, Van der Kwast TH, et al. Ki-67 immu-nostaining in uveal melanoma. The effect of pre-enucleation radiotherapy. Ophthalmology. 1990;97:1275-1280.
10. Bardenstein DS, Char DH, Kaleta-Michaels S, et al. Ki-67 and bromodeoxyuridine labeling of human choroidal melanoma cells. Curr Eye Res. 1991;10:479-484.
11. Karlsson M, Boeryd B, Carstensen J, et al. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and sur vival in uveal melanoma. Eur J Cancer. 1996;32A:357-362.
12. Chowers I, Folberg R, Livni N, et al. p53 immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid. Curr Eye Res. 2002;24:105-108.
13. Al-Jamal RT, Kivela T. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors. Curr Eye Res. 2006;31:57-67.
14. Chowers I, Folberg R, Livni N, et al. Comparison of micro-circulation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma. Ophthalmology. 2001;108:367-371.
15. Onken MD, Ehlers JP, Worley LA, et al. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 2006;66:4602-4609.
16. Onken MD, Lin AY, Worley LA, et al. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Oph-thalmol. 2005;140:748-749.
17. Onken MD, Worley LA, Person E, et al. Loss of heterozy-gosity of chromosome 3 detected swith single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res. 2007;13:2923-2927.
18. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer. 2009:9:153-166.